STOCKHOLM--(BUSINESS WIRE)--Diamyd Medical (STO:DIAMB) (Pink Sheets:DMYDY) In connection with the exercise of employee stock options in the stock option plan 2007/2010, 100,000 new shares of series B have been issued, with support of underlying warrants that covers the company’s obligations under the plan. The shares have been placed with an institutional investor.
